BioRap Technologies Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:BioRap Technologies Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10905
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BioRap Technologies Ltd (BioRap) is a technology transfer company that offers biomedical solutions for contemporary health care industry. The company’s technologies are used in the treatment of macular disease, alopecia, cardiovascular disease, cancer and autoimmune diseases, cancer therapy, blood coagulation, multiple sclerosis, inflammatory bowel disease, prostate cancer, chronic colitis and colitis-associated cancer, and diabetes. Its technologies are used in the therapeutic areas of oncology, neurology, cardiology, hematology, and dermatology. The company caters to biopharmaceutical, medical devices, and medical diagnostic sectors. It serves its clients in Israel and abroad. BioRap is headquartered in Haifa City, Israel.

BioRap Technologies Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BioRap Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioRap Technologies Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BioRap Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioRap Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BioRap Technologies Ltd, Medical Devices Deals, 2012 to YTD 2018 9
BioRap Technologies Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
BioRap Technologies Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
BioRap Technologies Enters into Co- Development Agreement with Pfizer 11
Fairjourney Biologics Enters Into Research Agreement With BioRap And Hadasit Medical To Develop Antibodies 12
BioRap Enters into Agreement with GlaxoSmithKline 13
BioRap Technologies Ltd – Key Competitors 14
BioRap Technologies Ltd – Key Employees 15
BioRap Technologies Ltd – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
BioRap Technologies Ltd, Pharmaceuticals & Healthcare, Key Facts 2
BioRap Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioRap Technologies Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BioRap Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioRap Technologies Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
BioRap Technologies Ltd, Medical Devices Deals, 2012 to YTD 2018 9
BioRap Technologies Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
BioRap Technologies Enters into Co- Development Agreement with Pfizer 11
Fairjourney Biologics Enters Into Research Agreement With BioRap And Hadasit Medical To Develop Antibodies 12
BioRap Enters into Agreement with GlaxoSmithKline 13
BioRap Technologies Ltd, Key Competitors 14
BioRap Technologies Ltd, Key Employees 15

List of Figures
BioRap Technologies Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
BioRap Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
BioRap Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
BioRap Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
BioRap Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioRap Technologies Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
BioRap Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioRap Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BioRap Technologies Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[BioRap Technologies Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Carnegie Private Bank:企業の戦略・SWOT・財務情報
    Carnegie Private Bank - Strategy, SWOT and Corporate Finance Report Summary Carnegie Private Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Ramba Energy Ltd (R14):石油・ガス:M&Aディール及び事業提携情報
    Summary Ramba Energy Ltd (Ramba Energy), a subsidiary of Redmount Holdings Ltd, is an oil and gas company that offers exploration and production of oil and gas properties in Indonesia. The company provides services such as inbound and outbound transportation activities, seaport and airport cargo han …
  • Groupe Lactalis S.A.:企業のM&A・事業提携・投資動向
    Groupe Lactalis S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Groupe Lactalis S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Obalon Therapeutics Inc (OBLN):製薬・医療:M&Aディール及び事業提携情報
    Summary Obalon Therapeutics Inc (Obalon Therapeutics) is a manufacturer of medical devices and equipment. The company offers development and commercializing medical devices to treat obese and overweight people by facilitating weight loss. It also researches, designs, produces, and sells medical gast …
  • The Cleveland Clinic Foundation:企業の戦略的SWOT分析
    The Cleveland Clinic Foundation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Denver Water:企業の戦略的SWOT分析
    Denver Water - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Cosmo Oil Co Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Cosmo Oil Co Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Cosmo Oil Co Ltd Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the o …
  • Isofol Medical AB (ISOFOL)-製薬・医療分野:企業M&A・提携分析
    Summary Isofol Medical AB (Isofol) is a clinical stage pharmaceutical company developing folate-based therapies for the treatment of cancer patients. The company’s clinical lead candidate Modufolin, a metabolite is under clinical phase I/II development being evaluated for the treatment of colorectal …
  • Cox & Kings Limited:企業の戦略・SWOT・財務分析
    Cox & Kings Limited - Strategy, SWOT and Corporate Finance Report Summary Cox & Kings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Etex Group Sa:企業の戦略・SWOT・財務分析
    Etex Group Sa - Strategy, SWOT and Corporate Finance Report Summary Etex Group Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Medicago Inc-製薬・医療分野:企業M&A・提携分析
    Summary Medicago Inc (Medicago), a subsidiary of Mitsubishi Tanabe Pharma Corp is a biopharmaceutical company that develops and produces vaccines and antibodies. The company concentrates on the discovery and development of novel vaccines and therapeutic proteins for infectious diseases. Its pipeline …
  • Infinity Pharmaceuticals Inc (INFI):企業の財務・戦略的SWOT分析
    Infinity Pharmaceuticals Inc (INFI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Viztek LLC-医療機器分野:企業M&A・提携分析
    Summary Viztek LLC (Viztek), a subsidiary of Konica Minolta Medical Imaging USA Inc is a healthcare technology company that offers digital software and hardware imaging solutions. The company offers products such as opal-ORTHO, Opal-wRIS, CR, opal-CR II, opal-CHIRO, opal-RAD, opal-CLOUD, Viztek DR, …
  • Avillion LLP:製薬・医療:M&Aディール及び事業提携情報
    Summary Avillion LLP (Avillion) is a provider of drug development services. The company supports pharmaceutical and biotechnology companies, that provides clinical development and approval of late stage pharmaceutical products and candidates. It maintains a business model for the clinical developmen …
  • ORBIT Communication Systems Ltd:企業の戦略・SWOT・財務情報
    ORBIT Communication Systems Ltd - Strategy, SWOT and Corporate Finance Report Summary ORBIT Communication Systems Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Catholic Health Initiatives:企業のM&A・事業提携・投資動向
    Catholic Health Initiatives - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Catholic Health Initiatives Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • GE Aviation:企業の戦略・SWOT・財務情報
    GE Aviation - Strategy, SWOT and Corporate Finance Report Summary GE Aviation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Canadian Tire Corp Ltd (CTC.A):企業の財務・戦略的SWOT分析
    Canadian Tire Corp Ltd (CTC.A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Nuverra Environmental Solutions Inc (NES):企業の財務・戦略的SWOT分析
    Nuverra Environmental Solutions Inc (NES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Autotelic Inc-製薬・医療分野:企業M&A・提携分析
    Summary Autotelic Inc (Autotelic) is a therapeutic drug monitoring company that develops novel treatments using its therapeutic drug monitoring (TDM) services. The company's pipeline products includes devices to improve safety and efficacy of COX-2 inhibitors, paclitaxel nanomedicine and TGF-beta in …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆